why choose us

First received: August 09, 2023

Clinical Trial: Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab

Study Status: Completed

Recruit Status: RECRUITING

Condition: Glioma

Study Type: INTERVENTIONAL


Official Title: A Pilot Study of APG-157 With Bevacizumab for Patients With Recurrent High-Grade Glioma

Brief Summary: The goal of this interventional study is to evaluate the efficacy of APG-157 in combination with Bevacizumab in subjects with recurrent high-grade glioma.The main questions the study aims to answer are:Progression-free and overall survival of patients receiving this combination;Quality of Life (QOL); andTumor response on imagingThe participants will take APG-157 daily by dissolving two pastilles in their mouth at around breakfast, lunch and dinner time (total of six pastilles per day).The pastilles dissolve in the…

Read more